Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study

•What is the prevalence and persistence of symptoms attributable to COVID-19 at 12 months after hospital discharge?.•Burden of the long COVID-19 symptoms decreased over time but remained as high as 40% at 12 months with important gender and functional differences. Fatigue, exertional dyspnea, insomn...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of internal medicine 2022-03, Vol.97, p.36-41
Hauptverfasser: Fumagalli, Carlo, Zocchi, Chiara, Tassetti, Luigi, Silverii, Maria Vittoria, Amato, Carla, Livi, Luca, Giovannoni, Lorenzo, Verrillo, Federica, Bartoloni, Alessandro, Marcucci, Rossella, Lavorini, Federico, Fumagalli, Stefano, Ungar, Andrea, Olivotto, Iacopo, Rasero, Laura, Fattirolli, Francesco, Marchionni, Niccoló
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 41
container_issue
container_start_page 36
container_title European journal of internal medicine
container_volume 97
creator Fumagalli, Carlo
Zocchi, Chiara
Tassetti, Luigi
Silverii, Maria Vittoria
Amato, Carla
Livi, Luca
Giovannoni, Lorenzo
Verrillo, Federica
Bartoloni, Alessandro
Marcucci, Rossella
Lavorini, Federico
Fumagalli, Stefano
Ungar, Andrea
Olivotto, Iacopo
Rasero, Laura
Fattirolli, Francesco
Marchionni, Niccoló
description •What is the prevalence and persistence of symptoms attributable to COVID-19 at 12 months after hospital discharge?.•Burden of the long COVID-19 symptoms decreased over time but remained as high as 40% at 12 months with important gender and functional differences. Fatigue, exertional dyspnea, insomnia, confusion, fear, depression, cough, and bowel symptoms were the most common symptoms at 12-month contact. Age, gender, chronic obstructive pulmonary Disease, >2 symptoms at baseline and frailty at baseline were associated with a higher probability of symptoms.•There is an unmet need to highlight potential patient categories who may benefit from specific follow up strategies. Objective: To investigate the persistence of symptoms compatible with COVID-19 in a real-file prospective cohort of patients at 12 months from hospital discharge. Methods: Longitudinal, prospective, single-center, cohort telephone follow-up (FU) study in a Tertiary Care Hospital. All consecutive patients >18 years admitted for COVID-19 were prospectively enrolled in a telephone FU program aimed at monitoring symptoms after 1,3,6,9 and 12 months from hospital discharge. The survey screened for somatic (fatigue, dyspnea, dyspnea, palpitations, cough, chest pain, abdominal pain, ageusia, anosmia, bowel symptoms) and emotional symptoms (insomnia, confusion, altered sense of reality, loss of appetite, fear, and depression) and frailty. Only patients with 12 months FU data were analyzed (N=254). Prevalence and factors associated with symptoms were the main outcomes. Frailty was defined by the presence of ≥3 indicators: weakness, slowness/impaired mobility, weight-loss, low physical activity, and exhaustion. Results: At 12 months, 40.5% of patients reported at least one symptom. The most common somatic ones were fatigue, exertional dyspnea, cough, bowel complaints while the most common psycho-emotional were insomnia, confusion, fear, and depression. Age, gender, gender, frailty, multiple symptoms at baseline and chronic obstructive pulmonary disease (COPD) were associated with symptoms persistence. Furthermore, frailty, COPD and multiple symptoms at baseline were associated with increased risk of somatic symptoms at 12 months, while age and gender were associated with emotional ones. Conclusions: Burden of the long COVID-19 symptoms decreased over time but remained as high as 40% at 12 months with important gender and functional differences, highlighting potential patient categories who may ben
doi_str_mv 10.1016/j.ejim.2021.11.018
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8648678</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0953620521004052</els_id><sourcerecordid>2610079379</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-d0f32d9c3b2c67da70384ba5b4b011f03fefb6678d04e517999ae3c85f119ff63</originalsourceid><addsrcrecordid>eNp9kc2KFDEURoMoTtv6Ai4kSxdWmVupn5TIwNA6OjAwG3UbUqmb6TRVlTJJddNP4SubpsdBN0Igi9zv5PIdQl4Dy4FB_X6X486OecEKyAFyBuIJWYFo2oyJQjwlK9ZWPKsLVl2QFyHsGIOGMf6cXPCyZbwsxYr8ulY6Oh-oCsFpqyL29GDjls7ogw0RJ43UGRqO4xzdGCjQIypPlYno6ebux82nDNoP9IoObrq3centpIZ3dPYuzKij3SOdt27CrFMhse2UcnuLB2rcMLhDtsxUu63zkYYUPr4kz4waAr56uNfk-_Xnb5uv2e3dl5vN1W2my6qKWc8ML_pW867QddOrhnFRdqrqyo4BGMYNmq6uG9GzEito2rZVyLWoDEBrTM3X5PLMnZduxF7jFL0a5OztqPxROmXlvy-T3cp7t5eiLkXiJsDbB4B3PxcMUY42aBwGNaFbgixqYKxpeTprUpxHdSoleDSP3wCTJ5NyJ08m5cmkBJDJZAq9-XvBx8gfdWng43kAU02pUS-DtiddvfWpeNk7-z_-b-wKs0A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2610079379</pqid></control><display><type>article</type><title>Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Fumagalli, Carlo ; Zocchi, Chiara ; Tassetti, Luigi ; Silverii, Maria Vittoria ; Amato, Carla ; Livi, Luca ; Giovannoni, Lorenzo ; Verrillo, Federica ; Bartoloni, Alessandro ; Marcucci, Rossella ; Lavorini, Federico ; Fumagalli, Stefano ; Ungar, Andrea ; Olivotto, Iacopo ; Rasero, Laura ; Fattirolli, Francesco ; Marchionni, Niccoló</creator><creatorcontrib>Fumagalli, Carlo ; Zocchi, Chiara ; Tassetti, Luigi ; Silverii, Maria Vittoria ; Amato, Carla ; Livi, Luca ; Giovannoni, Lorenzo ; Verrillo, Federica ; Bartoloni, Alessandro ; Marcucci, Rossella ; Lavorini, Federico ; Fumagalli, Stefano ; Ungar, Andrea ; Olivotto, Iacopo ; Rasero, Laura ; Fattirolli, Francesco ; Marchionni, Niccoló ; AOU Careggi COVID-19 Follow-up study Group</creatorcontrib><description>•What is the prevalence and persistence of symptoms attributable to COVID-19 at 12 months after hospital discharge?.•Burden of the long COVID-19 symptoms decreased over time but remained as high as 40% at 12 months with important gender and functional differences. Fatigue, exertional dyspnea, insomnia, confusion, fear, depression, cough, and bowel symptoms were the most common symptoms at 12-month contact. Age, gender, chronic obstructive pulmonary Disease, &gt;2 symptoms at baseline and frailty at baseline were associated with a higher probability of symptoms.•There is an unmet need to highlight potential patient categories who may benefit from specific follow up strategies. Objective: To investigate the persistence of symptoms compatible with COVID-19 in a real-file prospective cohort of patients at 12 months from hospital discharge. Methods: Longitudinal, prospective, single-center, cohort telephone follow-up (FU) study in a Tertiary Care Hospital. All consecutive patients &gt;18 years admitted for COVID-19 were prospectively enrolled in a telephone FU program aimed at monitoring symptoms after 1,3,6,9 and 12 months from hospital discharge. The survey screened for somatic (fatigue, dyspnea, dyspnea, palpitations, cough, chest pain, abdominal pain, ageusia, anosmia, bowel symptoms) and emotional symptoms (insomnia, confusion, altered sense of reality, loss of appetite, fear, and depression) and frailty. Only patients with 12 months FU data were analyzed (N=254). Prevalence and factors associated with symptoms were the main outcomes. Frailty was defined by the presence of ≥3 indicators: weakness, slowness/impaired mobility, weight-loss, low physical activity, and exhaustion. Results: At 12 months, 40.5% of patients reported at least one symptom. The most common somatic ones were fatigue, exertional dyspnea, cough, bowel complaints while the most common psycho-emotional were insomnia, confusion, fear, and depression. Age, gender, gender, frailty, multiple symptoms at baseline and chronic obstructive pulmonary disease (COPD) were associated with symptoms persistence. Furthermore, frailty, COPD and multiple symptoms at baseline were associated with increased risk of somatic symptoms at 12 months, while age and gender were associated with emotional ones. Conclusions: Burden of the long COVID-19 symptoms decreased over time but remained as high as 40% at 12 months with important gender and functional differences, highlighting potential patient categories who may benefit from specific follow up strategies.</description><identifier>ISSN: 0953-6205</identifier><identifier>EISSN: 1879-0828</identifier><identifier>DOI: 10.1016/j.ejim.2021.11.018</identifier><identifier>PMID: 34903448</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Cohort Studies ; COVID-19 ; COVID-19 - complications ; Follow-Up Studies ; Frailty ; Gender medicine ; Humans ; Long-COVID ; Prognosis ; Prospective Studies ; SARS-CoV-2 ; Symptoms</subject><ispartof>European journal of internal medicine, 2022-03, Vol.97, p.36-41</ispartof><rights>2021 European Federation of Internal Medicine</rights><rights>Copyright © 2021 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.</rights><rights>2021 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved. 2021 European Federation of Internal Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-d0f32d9c3b2c67da70384ba5b4b011f03fefb6678d04e517999ae3c85f119ff63</citedby><cites>FETCH-LOGICAL-c455t-d0f32d9c3b2c67da70384ba5b4b011f03fefb6678d04e517999ae3c85f119ff63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejim.2021.11.018$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,315,781,785,886,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34903448$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fumagalli, Carlo</creatorcontrib><creatorcontrib>Zocchi, Chiara</creatorcontrib><creatorcontrib>Tassetti, Luigi</creatorcontrib><creatorcontrib>Silverii, Maria Vittoria</creatorcontrib><creatorcontrib>Amato, Carla</creatorcontrib><creatorcontrib>Livi, Luca</creatorcontrib><creatorcontrib>Giovannoni, Lorenzo</creatorcontrib><creatorcontrib>Verrillo, Federica</creatorcontrib><creatorcontrib>Bartoloni, Alessandro</creatorcontrib><creatorcontrib>Marcucci, Rossella</creatorcontrib><creatorcontrib>Lavorini, Federico</creatorcontrib><creatorcontrib>Fumagalli, Stefano</creatorcontrib><creatorcontrib>Ungar, Andrea</creatorcontrib><creatorcontrib>Olivotto, Iacopo</creatorcontrib><creatorcontrib>Rasero, Laura</creatorcontrib><creatorcontrib>Fattirolli, Francesco</creatorcontrib><creatorcontrib>Marchionni, Niccoló</creatorcontrib><creatorcontrib>AOU Careggi COVID-19 Follow-up study Group</creatorcontrib><title>Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study</title><title>European journal of internal medicine</title><addtitle>Eur J Intern Med</addtitle><description>•What is the prevalence and persistence of symptoms attributable to COVID-19 at 12 months after hospital discharge?.•Burden of the long COVID-19 symptoms decreased over time but remained as high as 40% at 12 months with important gender and functional differences. Fatigue, exertional dyspnea, insomnia, confusion, fear, depression, cough, and bowel symptoms were the most common symptoms at 12-month contact. Age, gender, chronic obstructive pulmonary Disease, &gt;2 symptoms at baseline and frailty at baseline were associated with a higher probability of symptoms.•There is an unmet need to highlight potential patient categories who may benefit from specific follow up strategies. Objective: To investigate the persistence of symptoms compatible with COVID-19 in a real-file prospective cohort of patients at 12 months from hospital discharge. Methods: Longitudinal, prospective, single-center, cohort telephone follow-up (FU) study in a Tertiary Care Hospital. All consecutive patients &gt;18 years admitted for COVID-19 were prospectively enrolled in a telephone FU program aimed at monitoring symptoms after 1,3,6,9 and 12 months from hospital discharge. The survey screened for somatic (fatigue, dyspnea, dyspnea, palpitations, cough, chest pain, abdominal pain, ageusia, anosmia, bowel symptoms) and emotional symptoms (insomnia, confusion, altered sense of reality, loss of appetite, fear, and depression) and frailty. Only patients with 12 months FU data were analyzed (N=254). Prevalence and factors associated with symptoms were the main outcomes. Frailty was defined by the presence of ≥3 indicators: weakness, slowness/impaired mobility, weight-loss, low physical activity, and exhaustion. Results: At 12 months, 40.5% of patients reported at least one symptom. The most common somatic ones were fatigue, exertional dyspnea, cough, bowel complaints while the most common psycho-emotional were insomnia, confusion, fear, and depression. Age, gender, gender, frailty, multiple symptoms at baseline and chronic obstructive pulmonary disease (COPD) were associated with symptoms persistence. Furthermore, frailty, COPD and multiple symptoms at baseline were associated with increased risk of somatic symptoms at 12 months, while age and gender were associated with emotional ones. Conclusions: Burden of the long COVID-19 symptoms decreased over time but remained as high as 40% at 12 months with important gender and functional differences, highlighting potential patient categories who may benefit from specific follow up strategies.</description><subject>Cohort Studies</subject><subject>COVID-19</subject><subject>COVID-19 - complications</subject><subject>Follow-Up Studies</subject><subject>Frailty</subject><subject>Gender medicine</subject><subject>Humans</subject><subject>Long-COVID</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>SARS-CoV-2</subject><subject>Symptoms</subject><issn>0953-6205</issn><issn>1879-0828</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc2KFDEURoMoTtv6Ai4kSxdWmVupn5TIwNA6OjAwG3UbUqmb6TRVlTJJddNP4SubpsdBN0Igi9zv5PIdQl4Dy4FB_X6X486OecEKyAFyBuIJWYFo2oyJQjwlK9ZWPKsLVl2QFyHsGIOGMf6cXPCyZbwsxYr8ulY6Oh-oCsFpqyL29GDjls7ogw0RJ43UGRqO4xzdGCjQIypPlYno6ebux82nDNoP9IoObrq3centpIZ3dPYuzKij3SOdt27CrFMhse2UcnuLB2rcMLhDtsxUu63zkYYUPr4kz4waAr56uNfk-_Xnb5uv2e3dl5vN1W2my6qKWc8ML_pW867QddOrhnFRdqrqyo4BGMYNmq6uG9GzEito2rZVyLWoDEBrTM3X5PLMnZduxF7jFL0a5OztqPxROmXlvy-T3cp7t5eiLkXiJsDbB4B3PxcMUY42aBwGNaFbgixqYKxpeTprUpxHdSoleDSP3wCTJ5NyJ08m5cmkBJDJZAq9-XvBx8gfdWng43kAU02pUS-DtiddvfWpeNk7-z_-b-wKs0A</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Fumagalli, Carlo</creator><creator>Zocchi, Chiara</creator><creator>Tassetti, Luigi</creator><creator>Silverii, Maria Vittoria</creator><creator>Amato, Carla</creator><creator>Livi, Luca</creator><creator>Giovannoni, Lorenzo</creator><creator>Verrillo, Federica</creator><creator>Bartoloni, Alessandro</creator><creator>Marcucci, Rossella</creator><creator>Lavorini, Federico</creator><creator>Fumagalli, Stefano</creator><creator>Ungar, Andrea</creator><creator>Olivotto, Iacopo</creator><creator>Rasero, Laura</creator><creator>Fattirolli, Francesco</creator><creator>Marchionni, Niccoló</creator><general>Elsevier B.V</general><general>European Federation of Internal Medicine. Published by Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220301</creationdate><title>Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study</title><author>Fumagalli, Carlo ; Zocchi, Chiara ; Tassetti, Luigi ; Silverii, Maria Vittoria ; Amato, Carla ; Livi, Luca ; Giovannoni, Lorenzo ; Verrillo, Federica ; Bartoloni, Alessandro ; Marcucci, Rossella ; Lavorini, Federico ; Fumagalli, Stefano ; Ungar, Andrea ; Olivotto, Iacopo ; Rasero, Laura ; Fattirolli, Francesco ; Marchionni, Niccoló</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-d0f32d9c3b2c67da70384ba5b4b011f03fefb6678d04e517999ae3c85f119ff63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Cohort Studies</topic><topic>COVID-19</topic><topic>COVID-19 - complications</topic><topic>Follow-Up Studies</topic><topic>Frailty</topic><topic>Gender medicine</topic><topic>Humans</topic><topic>Long-COVID</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>SARS-CoV-2</topic><topic>Symptoms</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fumagalli, Carlo</creatorcontrib><creatorcontrib>Zocchi, Chiara</creatorcontrib><creatorcontrib>Tassetti, Luigi</creatorcontrib><creatorcontrib>Silverii, Maria Vittoria</creatorcontrib><creatorcontrib>Amato, Carla</creatorcontrib><creatorcontrib>Livi, Luca</creatorcontrib><creatorcontrib>Giovannoni, Lorenzo</creatorcontrib><creatorcontrib>Verrillo, Federica</creatorcontrib><creatorcontrib>Bartoloni, Alessandro</creatorcontrib><creatorcontrib>Marcucci, Rossella</creatorcontrib><creatorcontrib>Lavorini, Federico</creatorcontrib><creatorcontrib>Fumagalli, Stefano</creatorcontrib><creatorcontrib>Ungar, Andrea</creatorcontrib><creatorcontrib>Olivotto, Iacopo</creatorcontrib><creatorcontrib>Rasero, Laura</creatorcontrib><creatorcontrib>Fattirolli, Francesco</creatorcontrib><creatorcontrib>Marchionni, Niccoló</creatorcontrib><creatorcontrib>AOU Careggi COVID-19 Follow-up study Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>European journal of internal medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fumagalli, Carlo</au><au>Zocchi, Chiara</au><au>Tassetti, Luigi</au><au>Silverii, Maria Vittoria</au><au>Amato, Carla</au><au>Livi, Luca</au><au>Giovannoni, Lorenzo</au><au>Verrillo, Federica</au><au>Bartoloni, Alessandro</au><au>Marcucci, Rossella</au><au>Lavorini, Federico</au><au>Fumagalli, Stefano</au><au>Ungar, Andrea</au><au>Olivotto, Iacopo</au><au>Rasero, Laura</au><au>Fattirolli, Francesco</au><au>Marchionni, Niccoló</au><aucorp>AOU Careggi COVID-19 Follow-up study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study</atitle><jtitle>European journal of internal medicine</jtitle><addtitle>Eur J Intern Med</addtitle><date>2022-03-01</date><risdate>2022</risdate><volume>97</volume><spage>36</spage><epage>41</epage><pages>36-41</pages><issn>0953-6205</issn><eissn>1879-0828</eissn><abstract>•What is the prevalence and persistence of symptoms attributable to COVID-19 at 12 months after hospital discharge?.•Burden of the long COVID-19 symptoms decreased over time but remained as high as 40% at 12 months with important gender and functional differences. Fatigue, exertional dyspnea, insomnia, confusion, fear, depression, cough, and bowel symptoms were the most common symptoms at 12-month contact. Age, gender, chronic obstructive pulmonary Disease, &gt;2 symptoms at baseline and frailty at baseline were associated with a higher probability of symptoms.•There is an unmet need to highlight potential patient categories who may benefit from specific follow up strategies. Objective: To investigate the persistence of symptoms compatible with COVID-19 in a real-file prospective cohort of patients at 12 months from hospital discharge. Methods: Longitudinal, prospective, single-center, cohort telephone follow-up (FU) study in a Tertiary Care Hospital. All consecutive patients &gt;18 years admitted for COVID-19 were prospectively enrolled in a telephone FU program aimed at monitoring symptoms after 1,3,6,9 and 12 months from hospital discharge. The survey screened for somatic (fatigue, dyspnea, dyspnea, palpitations, cough, chest pain, abdominal pain, ageusia, anosmia, bowel symptoms) and emotional symptoms (insomnia, confusion, altered sense of reality, loss of appetite, fear, and depression) and frailty. Only patients with 12 months FU data were analyzed (N=254). Prevalence and factors associated with symptoms were the main outcomes. Frailty was defined by the presence of ≥3 indicators: weakness, slowness/impaired mobility, weight-loss, low physical activity, and exhaustion. Results: At 12 months, 40.5% of patients reported at least one symptom. The most common somatic ones were fatigue, exertional dyspnea, cough, bowel complaints while the most common psycho-emotional were insomnia, confusion, fear, and depression. Age, gender, gender, frailty, multiple symptoms at baseline and chronic obstructive pulmonary disease (COPD) were associated with symptoms persistence. Furthermore, frailty, COPD and multiple symptoms at baseline were associated with increased risk of somatic symptoms at 12 months, while age and gender were associated with emotional ones. Conclusions: Burden of the long COVID-19 symptoms decreased over time but remained as high as 40% at 12 months with important gender and functional differences, highlighting potential patient categories who may benefit from specific follow up strategies.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>34903448</pmid><doi>10.1016/j.ejim.2021.11.018</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0953-6205
ispartof European journal of internal medicine, 2022-03, Vol.97, p.36-41
issn 0953-6205
1879-0828
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8648678
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Cohort Studies
COVID-19
COVID-19 - complications
Follow-Up Studies
Frailty
Gender medicine
Humans
Long-COVID
Prognosis
Prospective Studies
SARS-CoV-2
Symptoms
title Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T09%3A22%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Factors%20associated%20with%20persistence%20of%20symptoms%201%20year%20after%20COVID-19:%20A%20longitudinal,%20prospective%20phone-based%20interview%20follow-up%20cohort%20study&rft.jtitle=European%20journal%20of%20internal%20medicine&rft.au=Fumagalli,%20Carlo&rft.aucorp=AOU%20Careggi%20COVID-19%20Follow-up%20study%20Group&rft.date=2022-03-01&rft.volume=97&rft.spage=36&rft.epage=41&rft.pages=36-41&rft.issn=0953-6205&rft.eissn=1879-0828&rft_id=info:doi/10.1016/j.ejim.2021.11.018&rft_dat=%3Cproquest_pubme%3E2610079379%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2610079379&rft_id=info:pmid/34903448&rft_els_id=S0953620521004052&rfr_iscdi=true